Sponsor or institution
Clinical trials and research at SPARK Biopharma
As of November 12, 2026, Find a Trial lists 2 clinical trials run by SPARK Biopharma that are recruiting, in South Korea. By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Evaluating SB17170 in patients with idiopathic pulmonary fibrosis
This study is testing a new drug called SB17170 to see if it can help adults with moderate to severe idiopathic pulmonary fibrosis breathe better over 12 weeks.
-
SB17170 for advanced and metastatic solid tumors
This trial tests SB17170 alone or with standard treatments in adults with advanced or metastatic solid tumors who have exhausted standard options to see if it is safe and shows anti-tumor activity.
Quick answers
How many clinical trials run by SPARK Biopharma are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.